Charakterisierung eines neuen Tumor Nekrose Faktor (TNF) Rezeptor 2 (TNFR2) Agonisten: Der heteromere, membranständige Ligand Lymphotoxin α\(_2\)β
- Alternative title
-
Characterization of a novel tumor necrosis factor (TNF) receptor 2 (TNFR2) agonist: the heteromeric, membrane bound ligand lymphotoxin α\(_2\)β
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Deutsch
- Notes
-
Würzburg, Universität Würzburg, Dissertation, 2021
- Keyword
-
Ligand
Rezeptor
Lymphotoxin
Tumor-Nekrose-Faktor
Agonist
Ligand
Agonist
Lymphotoxin
- Event
-
Veröffentlichung
- (where)
-
Würzburg
- (who)
-
Universität Würzburg
- (when)
-
2021
- Creator
-
Kucka, Kirstin Michaela
- Contributor
-
Wajant, Harald
- DOI
-
10.25972/OPUS-24982
- URN
-
urn:nbn:de:bvb:20-opus-249824
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kucka, Kirstin Michaela
- Wajant, Harald
- Universität Würzburg
Time of origin
- 2021
Other Objects (12)
Generierung und Charakterisierung rekombinanter TNF-Liganden
Apoptoseregulation durch TNF im Multiplen Myelom
Enhancement of Toll-like receptor3 (TLR3)-induced death signaling by TNF-like weak inducer of apoptosis (TWEAK)
Molecular mode of action of TRAIL receptor agonists—common principles and their translational exploitation
Regulation Tumornekrosefaktor (TNF) Rezeptor assoziierter Signalwege durch das Adapterprotein TRAF1
A TNF Receptor 2 Selective Agonist Rescues Human Neurons from Oxidative Stress-Induced Cell Death
Development of self-adjusting cytokine neutralizer cells as a closed-loop delivery system of anti-inflammatory biologicals
Dual Antigen-Restricted Complementation of a Two-Part Trispecific Antibody for Targeted Immunotherapy of Blood Cancer
CD40-restringierte Aktivierung der TRAIL-Todesrezeptoren durch bifunktionelle rekombinante Proteine
Development of Modified polylysine based antibody conjugated nanoparticles with tumor-restricted, FcγR-independent stimulatory activity by targeting Fn14
Development of CD40-targeted bifunctional scFv-TRAIL fusion proteins that induce TRAILR1- and TRAILR2-specifc cell death and dendritic cells activation
CD70-abhängige und spezifische Aktivierung von TRAILR1 oder TRAILR2 durch scFv:CD70-TRAIL-Mutanten
Generierung und Charakterisierung rekombinanter TNF-Liganden
Apoptoseregulation durch TNF im Multiplen Myelom
Enhancement of Toll-like receptor3 (TLR3)-induced death signaling by TNF-like weak inducer of apoptosis (TWEAK)
Molecular mode of action of TRAIL receptor agonists—common principles and their translational exploitation
Regulation Tumornekrosefaktor (TNF) Rezeptor assoziierter Signalwege durch das Adapterprotein TRAF1
A TNF Receptor 2 Selective Agonist Rescues Human Neurons from Oxidative Stress-Induced Cell Death
Development of self-adjusting cytokine neutralizer cells as a closed-loop delivery system of anti-inflammatory biologicals
Dual Antigen-Restricted Complementation of a Two-Part Trispecific Antibody for Targeted Immunotherapy of Blood Cancer
CD40-restringierte Aktivierung der TRAIL-Todesrezeptoren durch bifunktionelle rekombinante Proteine
Development of Modified polylysine based antibody conjugated nanoparticles with tumor-restricted, FcγR-independent stimulatory activity by targeting Fn14
Development of CD40-targeted bifunctional scFv-TRAIL fusion proteins that induce TRAILR1- and TRAILR2-specifc cell death and dendritic cells activation
CD70-abhängige und spezifische Aktivierung von TRAILR1 oder TRAILR2 durch scFv:CD70-TRAIL-Mutanten
Generierung und Charakterisierung rekombinanter TNF-Liganden
Apoptoseregulation durch TNF im Multiplen Myelom
Enhancement of Toll-like receptor3 (TLR3)-induced death signaling by TNF-like weak inducer of apoptosis (TWEAK)
Molecular mode of action of TRAIL receptor agonists—common principles and their translational exploitation
Regulation Tumornekrosefaktor (TNF) Rezeptor assoziierter Signalwege durch das Adapterprotein TRAF1
A TNF Receptor 2 Selective Agonist Rescues Human Neurons from Oxidative Stress-Induced Cell Death
Development of self-adjusting cytokine neutralizer cells as a closed-loop delivery system of anti-inflammatory biologicals
Dual Antigen-Restricted Complementation of a Two-Part Trispecific Antibody for Targeted Immunotherapy of Blood Cancer
CD40-restringierte Aktivierung der TRAIL-Todesrezeptoren durch bifunktionelle rekombinante Proteine
Development of Modified polylysine based antibody conjugated nanoparticles with tumor-restricted, FcγR-independent stimulatory activity by targeting Fn14
Development of CD40-targeted bifunctional scFv-TRAIL fusion proteins that induce TRAILR1- and TRAILR2-specifc cell death and dendritic cells activation